Valuation: Qlucore AB

Market Cap 1.57Cr 15.58L 13.84L 12.94L 11.8L 22.21L 15Cr 22.51L 60.62L 7.64Cr 58.51L 57.24L 25Cr P/E 2025
-0.35x
P/E 2026 -0.38x
Enterprise Value 1.41Cr 14.02L 12.45L 11.65L 10.61L 19.98L 14Cr 20.26L 54.54L 6.88Cr 52.64L 51.5L 22Cr EV / Sales 2025
0.21x
EV / Sales 2026 1.77x
Free-Float
23.73%
Yield 2025 *
-
Yield 2026 -
1 day-1.08%
1 week+7.04%
Current month-1.08%
1 month-14.92%
3 months+26.30%
6 months-8.75%
Current year-26.71%
1 week 0.31
Extreme 0.309
0.41
1 month 0.31
Extreme 0.309
0.49
Current year 0.21
Extreme 0.213
0.58
1 year 0.21
Extreme 0.213
0.58
3 years 0.21
Extreme 0.213
11.5
5 years 0.21
Extreme 0.213
58
10 years 0.21
Extreme 0.213
58
Manager TitleAgeSince
Chief Executive Officer 58 05/12/2006
Director of Finance/CFO - 01/02/2022
Chief Tech/Sci/R&D Officer - 07/02/2022
Director TitleAgeSince
Chairman 72 01/01/2018
Director/Board Member 68 01/01/2007
Director/Board Member 63 05/12/2006
Change 5-day change 1-year change 3-year change Capi.($)
-1.08%+7.04%-27.00%-96.42% 15.86L
-0.02%+2.99%-1.33%+62.41% 3,80900Cr
+1.60%-1.32%+2.75%+1,087.75% 45TCr
+0.56%-1.05%-52.23%+30.35% 42TCr
-0.27%+1.62%+91.61%+238.04% 32TCr
+0.51%+2.47%+112.89%+535.89% 27TCr
+0.58%+1.39%-18.02%+52.04% 24TCr
+2.80%-0.01%-24.51%+23.23% 14TCr
-0.02%+0.03%+109.81%+204.57% 13TCr
+0.95%+7.61%+81.05%+203.50% 9.83TCr
Average +0.23%+1.08%+27.50%+234.14% 58.82TCr
Weighted average by Cap. +0.94%+1.73%+8.41%+174.24%

Financials

2025 2026
Net sales 1.84Cr 18.34L 16.29L 15.23L 13.88L 26.14L 18Cr 26.5L 71.34L 8.99Cr 68.86L 67.37L 29Cr 1.04Cr 10.31L 9L 9L 8L 14.69L 9.93Cr 14.9L 40.11L 5.06Cr 38.72L 37.88L 16Cr
Net income -2.05Cr -20.44L -18.15L -16.97L -15.47L -29.12L -20Cr -29.52L -79.49L -10Cr -76.73L -75.06L -32Cr -3.65Cr -36.35L -32.28L -30.19L -27.51L -51.79L -35Cr -52.51L -1.41Cr -18Cr -1.36Cr -1.34Cr -57Cr
Net Debt -32.58L -3L -3L -3L -2L -5L -3.12Cr -5L -12.61L -1.59Cr -12.17L -11.91L -5.11Cr -15.69L -2L -1L -1L -1L -2L -1.5Cr -2L -6L -76.56L -6L -6L -2.46Cr
Logo Qlucore AB
Qlucore AB (publ) is a Sweden-based company primarily engaged in the software industry. The Company’s scope of activity revolves around developing Artificial-Intelligence-based (AI-based) software dedicated to the healthcare sector. The software’s aim is to establish a platform improving cancer care in terms of treatment strategies, and more, as well as other therapy areas. What is more, the Firm develops software which is committed to data analysis in relation to medical research. The Company’s software relies on AI-based machine learning and functions by transforming data sets into explanatory visualizations. Additionally, the Firm runs three software products: Qlucore Omics Explorer, Qlucore Diagnostics, as well as Qlucore Insights.
Employees
12
Date Price Change Volume
01/26/01 SEK 0.3650 -1.08% 1,246
30/26/30 SEK 0.3690 0.00% 14,100
29/26/29 SEK 0.3690 -4.16% 8,761
28/26/28 SEK 0.3850 +7.54% 1,03,801
25/26/25 SEK 0.3580 +4.99% 9,224
  1. Stock Market
  2. Stocks
  3. QCORE Stock